Atopic Dermatitis is a very common skin disease affecting up to 20% of the general population. Dermatitis is characterized by a Th2 inflammatory response associated with epidermal barrier defects. Intense pruritis and colonization by Staphylococcus aureus  exacerbate the inflammatory process and therefore the lesions.

StratiCELL has developed 3D in vitro skin models displaying atopic dermatitis features to study the efficacy of dermo-cosmetic active ingredients and skin care products to restore the skin barrier and reduce inflammation of atopic and sensitive skins.

In vitro efficacy testing related to Staphylococcus infections are also available in the MicroBIOS Platform, such as reconstructed human epidermis relicating the overgrowth of Staphylococcus aureus in the presence of Staphylococcus epidermidis.

Visit the MicroBIOS Platform here.

Download our Atopic Dermatitis brochure

Feel free to download our brochure to have more informations.